首页 | 本学科首页   官方微博 | 高级检索  
检索        

激活增强子结合蛋白4在胃癌中的表达及其临床意义
引用本文:聂家艳,' target='_blank'>,陶文惠,' target='_blank'>.激活增强子结合蛋白4在胃癌中的表达及其临床意义[J].现代肿瘤医学,2018,0(23):3783-3787.
作者姓名:聂家艳  ' target='_blank'>  陶文惠  ' target='_blank'>
作者单位:1.武汉大学中南医院消化内科,湖北 武汉 430071;2.湖北省肠病医学临床研究中心&肠病湖北省重点实验室,湖北 武汉 430071
摘    要:目的:探讨激活增强子结合蛋白4(activating enhancer binding protein 4,AP4)在胃癌组织中的表达及其与临床病理特征的关系。方法:采用RT-PCR和Western blot检测胃癌细胞株BGC823和正常胃上皮细胞中AP4 mRNA和蛋白的表达;应用RT-PCR及免疫组化法检测90例胃癌组织中AP4 mRNA和蛋白的表达;进一步采用Log-rank检验和Cox回归模型对结直肠癌患者的预后因素进行分析,并用Kaplan-Meier计算不同AP4表达情况患者的生存率曲线。结果:与正常胃上皮细胞相比,胃癌细胞株BGC823中AP4 mRNA和蛋白的表达水平均显著升高(均P<0.05);在胃癌组织中,AP4 mRNA的表达水平也明显高于配对的癌旁组织(3.848±0.426 vs 1.411±0.405,P<0.05);在蛋白水平,胃癌组织也显著高于配对的癌旁组织,且AP4蛋白表达与胃癌的脉管浸润(P<0.05)、浸润深度(P<0.05)及TNM分期(P<0.05)相关,而与患者的性别、年龄、分化程度、肿瘤位置、淋巴结转移和远处转移无关(均P>0.05);Kaplan-Meier 单因素回归分析显示,AP4蛋白是影响胃癌患者预后的重要因素(P<0.05),进一步Cox多因素回归分析显示AP4蛋白是胃癌患者的独立预后因素(P<0.05)。结论:AP4高表达与胃癌的发生、发展、转移及预后关系密切,可能成为协助胃癌诊断和治疗的新的生物标志物。

关 键 词:胃癌  激活增强子结合蛋白4  免疫组化  预后

The significance of activating enhancer binding protein 4 expression in gastric cancer
Nie Jiayan,' target='_blank'>,Tao Wenhui,' target='_blank'>.The significance of activating enhancer binding protein 4 expression in gastric cancer[J].Journal of Modern Oncology,2018,0(23):3783-3787.
Authors:Nie Jiayan  ' target='_blank'>  Tao Wenhui  ' target='_blank'>
Institution:1.Department of Gastroenterology,Zhongnan Hospital of Wuhan University,Hubei Wuhan 430071,China;2.Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Diseases,Hubei Wuhan 430071,China.
Abstract:Objective:To investigate the expression and correlation with clinicopathological parameters of activating enhancer binding protein 4 (AP4) in gastric cancer.Methods:AP4 expression in BGC823 and normal gastric cells was detected by RT-PCR and Western blot.The mRNA and protein expression of AP4 in 90 gastric cancer tissues and paired adjacent tissues of 90 cases were investigated by RT-PCR and immunohistochemical SP method.Kaplan-Meier survival curves,Log-rank test and Cox multivariate test regression were used to analyze the clinicopathological prognostic factors of gastric cancer.Results:The mRNA and protein expression of AP4 in gastric cancer cell line (BGC823) was higher than normal gastric cells (P<0.05,respectively).AP4 was highly expressed at mRNA levels in the gastric tissue samples compared with the paired adjacent normal tissues (3.848±0.426 vs 1.411±0.405,P<0.05).Furthermore,compared to paired adjacent tissue,AP4 protein was highly expressed in gastric cancer tissue and the expression level of AP4 protein was significantly associated with vascular invasion (P<0.05),depth of invasion (P<0.05) and TNM stage (P<0.05),but not to gender,age,differential degree,tumor site,lymph node metastasis and distant metastasis (P>0.05,respectively).Kaplan-Meier univariate analysis showed that AP4 protein was an important factor for affecting the prognosis of gastric cancer (P<0.05),and further Cox regression analysis demonstrated that AP4 protein was an independent prognostic risk factor of gastric cancer (P<0.05).Conclusion:The high expression of AP4 is closely related to the occurrence,development,metastasis and prognosis of gastric cancer,and it may become a new biomarker to assist in the diagnosis and treatment of gastric cancer.
Keywords:gastric cancer  AP4  immunochemistry  prognosis
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号